Aviance Capital Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Sell
2,680
-400
-13% -$45.4K 0.03% 320
2025
Q4
$311K Hold
3,080
0.04% 302
2025
Q3
$380K Hold
3,080
0.05% 271
2025
Q2
$370K Hold
3,080
0.05% 260
2025
Q1
$454K Sell
3,080
-100
-3% -$15.3K 0.06% 225
2024
Q4
$516K Buy
3,180
+100
+3% +$16.4K 0.07% 210
2024
Q3
$502K Buy
3,080
+80
+3% +$11.9K 0.07% 223
2024
Q2
$409K Hold
3,000
0.06% 227
2024
Q1
$459K Buy
+3,000
New +$448K 0.07% 217

Other funds holding CLX

Aviance Capital Partners's CLX Position: Q1 2026 in Review

Aviance Capital Partners reduced its Clorox (CLX) stake by 13% in Q1 2026, selling an estimated $45.4K and leaving 2,680 shares worth $278K. The position accounts for 0.03% of the portfolio, ranked #320.

Aviance Capital Partners first reported a position in CLX in Q1 2024 and has held it in 9 quarters since. The position peaked at $516K in Q4 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Aviance Capital Partners held 2,680 shares of Clorox worth $278K as of Q1 2026.
  • Aviance Capital Partners sold 400 Clorox shares in Q1 2026, an estimated $45.4K.
  • Clorox made up 0.03% of Aviance Capital Partners's portfolio in Q1 2026, its #320 holding.
  • Aviance Capital Partners first reported a position in Clorox in Q1 2024 and has held it in 9 quarters since.
  • Aviance Capital Partners's Clorox position peaked at $516K in Q4 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.